vancomycin has been researched along with Infections, Helicobacter in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Ding, C; Doyle, T; Duncan, L; Ebright, RH; He, S; Lin, W; Liu, Y; Lynch, AS; Ma, Z; Molodtsov, V; Nguyen, P; Pulse, M; Robertson, GT; Wang, H; Weiss, WJ; Xu, X; Yuan, Y; Zhuang, Z | 1 |
| Cojocariu, C; Dorobat, C; Girleanu, I; Grigore, L; Sfarti, C; Singeap, AM; Stanciu, C; Trifan, A | 1 |
| Bubenik, S; Heineman, J; Martindale, R; McClave, S | 1 |
1 review(s) available for vancomycin and Infections, Helicobacter
| Article | Year |
|---|---|
Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases?
Topics: Bacterial Infections; Drug Resistance, Bacterial; Enterococcus; Enterocolitis, Necrotizing; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Pneumonia, Ventilator-Associated; Probiotics; Vancomycin | 2012 |
2 other study(ies) available for vancomycin and Infections, Helicobacter
| Article | Year |
|---|---|
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Topics: Anaerobiosis; DNA-Directed RNA Polymerases; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Rifamycins | 2022 |
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Pantoprazole; Proton Pump Inhibitors; Risk Factors; Treatment Outcome; Vancomycin | 2013 |